Thrombin and histamine stimulate endothelial nitric-oxide synthase phosphorylation at Ser1177 via an AMPK mediated pathway independent of PI3K-Akt

被引:71
|
作者
Thors, B
Halldórsson, H
Thorgeirsson, G
机构
[1] Univ Iceland, Inst Pharm Pharmacol & Toxicol, Reykjavik, Iceland
[2] Landspitali Univ Hosp, Dept Med, Reykjavik, Iceland
关键词
eNOS; AMPK; histamine; thrombin; endothelial cell;
D O I
10.1016/j.febslet.2004.07.078
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Histamine and thrombin cause phosphorylation and activation of endothelial NO-synthase (eNOS) on Ser1177. We tested the role of various protein kinases in mediating this effect in human umbilical vein endothelial cells. Inhibition of the Ca2+/ calmodulin-dependent protein kinase 11 or phosphoinositide 3-kinase (PI3K) had no effect. H89, an inhibitor of both protein kinase A (PKA) and 5'-AMP-activated protein kinase (AMPK), strongly inhibited phosphorylation and activity of eNOS. Conversely, the PKA inhibitor Rp-adenosine 3'5'-cyclic monophosphate (cAMPS) had no effect and eNOS was not phosphorylated by treatments that affect cAMP levels. Thrombin and histamine caused phosphorylation of AMPK on Thr172 as well as on its' downstream target acetyl-CoA carboxylase. Activation of AMPK using AICAR or CCCP also resulted in eNOS phosphorylation. We conclude that histamine and thrombin cause eNOS phosphorylation in an AMPK mediated manner, independent of PI3K-Akt. (C) 2004 Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.
引用
收藏
页码:175 / 180
页数:6
相关论文
共 50 条
  • [21] B7-H3 increases thymidylate synthase expression via the PI3k-Akt pathway
    Jiang, Bo
    Liu, Fen
    Liu, ZhiHui
    Zhang, Ting
    Hua, Dong
    TUMOR BIOLOGY, 2016, 37 (07) : 9465 - 9472
  • [22] Regulation of vascular endothelial growth factor expression by EMMPRIN via the PI3K-Akt signaling pathway
    Tang, Yi
    Nakada, Marian T.
    Rafferty, Patricia
    Laraio, Jenny
    McCabe, Francis L.
    Millar, Hillary
    Cunningham, Mark
    Snyder, Linda A.
    Bugelski, Peter
    Yan, Li
    MOLECULAR CANCER RESEARCH, 2006, 4 (06) : 371 - 377
  • [23] Compound K, a metabolite of ginsenosides, induces cardiac protection mediated nitric oxide via Akt/PI3K pathway
    Tsutsumi, Yasuo M.
    Tsutsumi, Rie
    Mawatari, Kazuaki
    Nakaya, Yutaka
    Kinoshita, Michiko
    Tanaka, Katsuya
    Oshita, Shuzo
    LIFE SCIENCES, 2011, 88 (15-16) : 725 - 729
  • [24] Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the PI3-kinase-Akt pathway in human endothelial cells
    Haynes, MP
    Sinha, D
    Russell, KS
    Collinge, M
    Fulton, D
    Morales-Ruiz, M
    Sessa, WC
    Bender, JR
    CIRCULATION RESEARCH, 2000, 87 (08) : 677 - 682
  • [25] Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the PI3-kinase-AKT pathway in human endothelial cells
    Haynes, MP
    Sinha, D
    Russell, KS
    Fulton, D
    Morales-Ruiz, M
    Sessa, WM
    Bender, JR
    CIRCULATION, 2000, 102 (18) : 225 - 226
  • [26] The antiproliferative effect of quercetin in cancer cells is mediated via inhibition of the PI3K-Akt/PKB pathway
    Gulati, N
    Laudet, B
    Zohrabian, VM
    Murali, R
    Jhanwar-Uniyal, M
    ANTICANCER RESEARCH, 2006, 26 (2A) : 1177 - 1181
  • [27] Azilsartan, an angiotensin II type 1 receptor blocker, restores endothelial function by reducing vascular inflammation and by increasing the phosphorylation ratio Ser1177/Thr497 of endothelial nitric oxide synthase in diabetic mice
    Sachiko Matsumoto
    Michio Shimabukuro
    Daiju Fukuda
    Takeshi Soeki
    Ken Yamakawa
    Hiroaki Masuzaki
    Masataka Sata
    Cardiovascular Diabetology, 13
  • [28] Valsartan Regulates Interaction of Angiotensin II Type 1 Receptor and Endothelial Nitric Oxide Synthase via Src/PI3 K/Akt Signaling Pathway
    Su, Kuo-Hui
    Tsai, Jin-Yi
    Kou, Yu Ru
    Wu, Yuh-Lin
    Shyue, Song-Kun
    Lee, Tzong-Shyuan
    FASEB JOURNAL, 2008, 22
  • [29] FoxO Transcription Factors Promote AKT Ser473 Phosphorylation and Renal Tumor Growth in Response to Pharmacologic Inhibition of the PI3K-AKT Pathway
    Lin, Aifu
    Piao, Hai-long
    Zhuang, Li
    Sarbassov, Dos D.
    Ma, Li
    Gan, Boyi
    CANCER RESEARCH, 2014, 74 (06) : 1682 - 1693
  • [30] Azilsartan, an angiotensin II type 1 receptor blocker, restores endothelial function by reducing vascular inflammation and by increasing the phosphorylation ratio Ser1177/Thr497 of endothelial nitric oxide synthase in diabetic mice
    Matsumoto, Sachiko
    Shimabukuro, Michio
    Fukuda, Daiju
    Soeki, Takeshi
    Yamakawa, Ken
    Masuzaki, Hiroaki
    Sata, Masataka
    CARDIOVASCULAR DIABETOLOGY, 2014, 13